A study to compare the clinical features of two drug combinations for injecting into backbone , such as ropivacaine 0.75% with fentanyl and ropivacaine 0.75% with morphine on patients undergoing day care surgeries in the anal region

A comparative study of intrathecal (0.75%) ropivacaine with fentanyl and intrathecal (0.75%) ropivacaine with morphine in day care perianal surgeries. - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065646

Enrollment

Registered

2024-04-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: ropivacaine with morphine: 1.5 ml of 11.25 mg of 0.75% ropivacaine with 0.1 ml of 100 mcg of morphine with 0.4 ml of normal saline given intrathecally. Control Intervention1: ropivacain

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients aged between 18 to 60 years of age posted for elective perianal surgeries. b) ASA grade I and II patient

Exclusion criteria

Exclusion criteria: a)Patients who has H/o coagulation and bleeding disorders. b) Infection at the site of spinal anesthesia c) H/o hypersensitivity to study drugs. d) Patients not giving consent

Design outcomes

Primary

Measure	Time frame
To compare the duration of analgesia in each group.Timepoint: 24 hours	—

Secondary

Measure	Time frame
1.Time to achieve S1 sensory block 2.Degree of motor block 3.Time taken for ambulation without assistance. 4.Complications if anyTimepoint: 24 hours	—

Countries

India

Contacts

Public ContactDr Shirley Paulina

DR B R Ambedkar medical college and hospital Bengaluru

shirlzz7291@gmail.com9482218232

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026